Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Methanone, (4-amino-1,3-dihydrofuro[3,4-c]naphthyridin-8-yl)[(3S)-3-[4-(trifluoromethyl)phenyl]-4-morpholiny | 2790567-82-5 | C22H19F3N4O3 | 250 MG
SDP

Supplier:  Medchemexpress LLC 250MGHY153390

Encompass_Preferred

AMG 193 is an orally active MTA-cooperative PRMT5 inhibitor with antitumor activity. When complexed with MTA, it preferentially inhibits the growth of MTAP-deficient tumor cells by inhibiting PRMT5, while protecting normal cells with wild-type MTAP. This compound is for research use only.

  • Preferentially inhibits the growth of MTAP-deficient tumor cells
  • Inhibits PRMT5 with an IC50 of 0.107 μM
  • Protects normal cells with wild-type MTAP
  • Induces alternative splicing defects, cell cycle arrest, and DNA damage response in MTAP-deficient HCT116 cells
  • Reduces S phase and increases G2/M cell population in MTAP-deficient cells
  • Dose-dependently inhibits tumor growth in MTAP-deficient xenograft mice
  • Causes tumor regression in 70% of mice with DLBCL tumors
  • Preserves normal hematopoietic cell lineages

Catalog No. 50-003-74437


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.